1. HBW Insight
  2. >>Leadership

Beautycounter Founder Returns As CEO; Inter Parfum’s FY2023 Results; Cosmetics News

 
• By Eileen Francis

Gregg Renfrew will start as CEO at the company she founded on 1 February. Separately, International Flavors & Fragrances taps J. Erik Fyrwald to succeed Frank Clyburn as CEO, Inter Parfums reports fiscal 2023 full-year results, Yellow Wood Partners acquires Chapstick, and more.

Woman announcing
• Source: Shutterstock

Beautycounter founder Gregg Renfrew will return to the company as CEO after selling the business in 2021 to the Carlyle Group, announces Counter Brands, LLC, a division of the private equity firm. In a 19 January release, the Santa Monica-based firm notes Renfrew, who will replace interim CEO and board director Mindy Mackenzie, will assume the role on 1 February. Counter Brands reported it was seeking a permanent replacement last summer. (Also see "L’Oreal Bets On Biotech; Beautycounter Launches CEO Search; NIVEA ‘Skin Out Loud’; Cosmetics News" - HBW Insight, 7 June, 2023.)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

FDA Leadership Shuffle Continues: Lowell Zeta Returns As OPDP, OGD Leaders Depart

 
• By Sue Sutter and Derrick Gingery

Lowell Zeta, a senior counselor at the FDA from 2020 to 2021, returns as deputy commissioner for strategic initiatives. The agency also names a new acting CIO and acting CVM director, but OGD's Ted Sherwood and OPDP's Catherine Gray retired.

Over The Counter: Brands, Brexit And New Self-Care Business Models, With PAGB’s Michelle Riddalls

 
• By David Ridley

HBW Insight catches up with UK OTC industry association CEO Michelle Riddalls to talk about digital self-care and the unrealized promise of Brexit - part 2.

Makary Suggests Combining All FDA Adverse Event Reporting Systems

 
• By Sarah Karlin-Smith

In discussing FDA’s adverse event monitoring, Makary also seemed to falsely imply the agency did not fully investigate the myocarditis signal with COVID-19 vaccines.

Third GOP Seat On Federal Trade Commission Goes To Former DoJ Attorney During Trump’s First Term

 
• By Malcolm Spicer

Mark Meador most recently worked as a visiting fellow at conservative think tank Heritage Foundation’s Tech Policy Center and worked during Trump’s first term as a trial attorney in the Department of Justice’s Antitrust Division. The two Democrat-appointee seats remain open while the members Trump recently fired contest his controversial decision.

More from HBW Insight

Bayer Study: Self-Care Is Hardest For Those Who Need It Most

 
• By David Ridley

Being poor makes it more likely that you will suffer from self-treatable health conditions but it also means you will find it harder to take advantage of self-care solutions, finds a recently-published study by Bayer Consumer Health and IQVIA.

Accelerating Natural Options Among US FDA’s Steps For Removing Petroleum-Based Food Dyes

 
• By Malcolm Spicer

HHS Secretary Kennedy commends food companies for cooperating, but also says, “We have them on the run now and we are going to win this battle. And four years from now, we're going to have most of these products off the market.”

Beiersdorf Repositioning In China Will Get Boost From Thiamidol Launch

 
• By Eileen Francis

Beiersdorf AG hit some initial bumps with a repositioning of its business in China, but the firm is optimistic about the rollout of Thiamidol Skin Care In 2026.